ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Creating Accurate, Efficient, And Effective CDMO Project Proposals

  To receive the most comprehensive project proposal possible, it is important to fill out any questionnaire as accurately and completely as possible.

• 3 IRT Tactics Being Used To Streamline Supply Logistics

  Shipping and storing leading-edge therapeutics require complex logistics, but enhanced automation and process simplification ensure that sites and patients have the drugs they need when they need them.

• Consolidating Clinical Supply Chain Operations With GxP Inventory

  A Japan-based biotechnology company leveraged Signant SmartSignals® GxP Inventory, which improved visibility, reduced risks and costs, and optimized operations in this case study.

• Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials

  Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.

• Practical Playbook For The Manual Assembly Of Combination Products

  Manual assembly plays a vital role in early‑phase combination product development. Learn how strong process design, collaboration, and quality controls help teams reduce risk, improve consistency, and move confidently toward later‑stage manufacturing.

• Powering Complex Personalized Medicine Oncology Trial

  Managing custom therapies requires a synchronized supply chain. Learn how to bridge the gap between manufacturing and clinical workflows to ensure seamless patient care in complex oncology trials.

• Global Clinical Supply Solutions For Every Trial

  A reliable clinical supply chain strategy is as essential as a company’s discovery program. Seek a partner who can help guide a comprehensive  strategy and manage day-to-day activities.

• Writing Effective Clinical Regulatory Documents For Therapy Trials

  Clinical medical writing for gene therapy regulatory documents is a demanding, detail-oriented task that diverges significantly from medical writing for more traditional therapies.

• Solutions For Sponsors Utilizing Drafted Guidance For PROs In Oncology

  Explore the challenges pharmaceutical companies face in implementing PROs in cancer clinical trials as outlined in the FDA’s draft guidance, as well as strategies to overcome these obstacles.

• 3 Reasons Sponsors Should Own The RTSM Vendor Relationship

  Explore how direct management of study randomization and supply chains reduces communication delays, improves system design, and protects clinical data integrity from accidental unblinding.